Page 4 - Evaluate Pharma News Today

Big pharma goes shopping as "patent cliff" puts more than $225 billion in revenues at risk.

Dublin, July 07, 2023 (GLOBE NEWSWIRE) -- The "3D Protein Structure Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,...

/PRNewswire/ -- The "3D Protein Structure Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added to...

After a series of milestone approvals in the first half of 2023, the FDA is slated to decide on four more firsts before the year’s end.

Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Rare Disease Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area...

The year’s first six months reveal a clear appetite for biopharma M&A, although an emboldened FTC has made dealmakers wary.

Dublin, June 05, 2023 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Services...

Key trends include fewer and slower financings, a surge of decisive data readouts for cancer vaccines, and further development of mRNA, cell, and gene therapies.

Key trends include fewer and slower financings, a surge of decisive data readouts for cancer vaccines, and further development of mRNA, cell, and gene therapies.

This article discusses three key themes in 2023 that are likely to have an outsized impact on biotech companies as well as the notable longer-term...